Studykik

Striving to have a positive impact on the global community through the advancement of new therapies via education and innovative technology, StudyKIK was introduced in 2014. It marked the inception of a ground-breaking global network of patient-centric communities, providing direct access to eligible patients across nearly every major therapeutic domain. Since then, the growth of these patient communities has been ongoing, alongside collaborative efforts with research sites and patients to develop superior tools and services, ultimately simplifying clinical trials on a global scale.